Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Go back to Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares| (NASDAQ: XENE) | Delayed: 69.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $69.95 | 52 Week High | $9.75 | |||
| Open | $69.95 | 52 Week Low | $5.65 | |||
| Day High | $69.95 | P/E | N/A | |||
| Day Low | $69.95 | EPS | $0.00 | |||
| Volume | 2,934 | |||||
| (NASDAQ: XENE) | Delayed: 69.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $69.95 | 52 Week High | $9.75 | |||
| Open | $69.95 | 52 Week Low | $5.65 | |||
| Day High | $69.95 | P/E | N/A | |||
| Day Low | $69.95 | EPS | $0.00 | |||
| Volume | 2,934 | |||||

